Page 3 - Nasdaq Bysi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BeyondSpring (NASDAQ:BYSI – Get Rating) and Enlivex Therapeutics (NASDAQ:ENLV – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, dividends, earnings and profitability. Profitability This table compares BeyondSpring and Enlivex Therapeutics’ net margins, […]

BeyondSpring (NASDAQ:BYSI – Get Rating) had its target price cut by analysts at Robert W. Baird from $4.00 to $1.25 in a research report issued to clients and investors on Tuesday, The Fly reports. Robert W. Baird’s price objective suggests a potential upside of 39.98% from the stock’s previous close. BeyondSpring Stock Down 5.6 % […]

Shares of BeyondSpring Inc. (NASDAQ:BYSI – Get Rating) have received a consensus recommendation of “Hold” from the six research firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating on the company. […]

BeyondSpring (NASDAQ:BYSI – Get Rating) and Processa Pharmaceuticals (NASDAQ:PCSA – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, risk, dividends and analyst recommendations. Valuation & Earnings This table compares BeyondSpring and Processa Pharmaceuticals’ […]

BeyondSpring (NASDAQ:BYSI – Get Rating) and IMARA (NASDAQ:IMRA – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership and dividends. Analyst Recommendations This is a breakdown of recent ratings and recommmendations […]